Aadi Bioscience, Inc. (AADI) Tops Q4 EPS by 5c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q4 EPS of ($0.60), $0.05 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.4 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Labcorp acquires MLM Medical Labs to expand lab network
• JPMorgan starts FedEx Freight at Overweight on post-spin turnaround